This trial will test an exercise intervention for secondary prevention of ADRD in adults at increased risk for ADRD. The rationale for this trial is the urgent need for dementia prevention.
1 Primary · 7 Secondary · Reporting Duration: Participants will be assessed at 6, 12 and 18 months.
Experimental Treatment
264 Total Participants · 1 Treatment Group
Primary Treatment: Aerobic exercise · No Placebo Group · N/A
Age 50 - 80 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: